| | |
ACTUAL TREATMENT
|
|---|
|
AASLD INDICATIONS
| |
RESECTION
|
OLTx
|
PEI/RFTA
|
TACE/
PEI+TACE
|
BSC
|
|---|
| |
RESECTION
|
30 (28%)
|
1 (1%)
|
44 (40%)
|
27 (25%)
|
7 (6%)
|
| |
OLTx
|
6 (9%)
|
6(9%)
|
9 (14%)
|
34 (52%)
|
11(16%)
|
| |
PEI or RFTA
|
32 (13%)
|
4 (2%)
|
83 (34%)
|
88 (36%)
|
37(15%)
|
- OLTx: orthotopic liver transplantation; RFTA: radiofrequency-mediated thermal ablation; PEI: percutaneous ethanol injection; TACE: transcatheter arterial chemoembolization; BSC: best supportive care.
- AASLD indications for treatment are reported in rows; percentages of patients treated per each modality are calculated on the totality of patients having that specific indication.
- The adherence to AASLD indication was evaluated when all data were available (419/465 pts – 90%).
